We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regeneron and UPenn Forge Gene Therapy Pact for COVID-19 Antibody Cocktail
Regeneron and UPenn Forge Gene Therapy Pact for COVID-19 Antibody Cocktail
Regeneron has partnered with the University of Pennsylvania (UPenn) to develop a gene therapy nasal delivery system for its COVID-19 antibody cocktail, casirivimab and imdevimab, which received an Emergency Use Authorization from the FDA last month for mild-to-moderately ill coronavirus patients at high risk.